Smoking Status in Relation to Clinicopathological Characteristics, Oncological Outcome, and Presence of Second Primary Lung Cancer in Patients with Bladder Cancer: A Population-based Registry Study

Basit Öğe Kaydı
dc.authoridAslan, Güven/0000-0003-3715-1761
dc.authoridGOKER, ERDEM/0000-0001-6180-713X
dc.contributor.authorBolat, Deniz
dc.contributor.authorTinay, Ilker
dc.contributor.authorAslan, Guven
dc.contributor.authorOzkok, Serdar
dc.contributor.authorGoker, Erdem
dc.contributor.authorAkkoclu, Atila
dc.date.accessioned2024-08-31T07:50:27Z
dc.date.available2024-08-31T07:50:27Z
dc.date.issued2023
dc.departmentEge Üniversitesien_US
dc.description.abstractObjective: To evaluate the relationship between smoking status and clinicopathological characteristics and oncological outcome in bladder cancer (BC) patients and those with concomitant BC and lung cancer (LC) who developed BC or LC as a second primary cancer during their survivorship.Materials and Methods: A total of 2621 BC patients registered in the Turkish Urooncology Association Bladder Cancer Database between 2001 and 2021 were retrospectively analyzed. Patients were divided into two groups: those with BC only (BC group, n=2568) and those with concomitant BC and LC (BLC group, n=53). Data on patient demographics and smoking status (active smoker, former smoker, non-smoker) were recorded, as were the clinicopathological characteristics and oncological outcomes with respect to smoking status.Results: Active smokers comprised 50.5% and 49.1% of patients in the BC and BLC groups, respectively. The percentage of former smokers was 14.3% and 13.2% and percentage of non-smokers was 31.4% and 18.9% in the BC and BLC groups, respectively. In both BC and BLC groups, a higher percentage of males than females were active smokers (45.8% vs. 4.6% in BC and 47.2% vs. 1.9% in BLC). In the BLC group, the percentages of active smokers, former smokers and non-smokers in the BC first group were 56.0%, 24.0% and 20.0%, respectively, whereas the corresponding ratios in the LC first group were 50.0%, 8.3%, and 41.7%, respectively. The presence of smoking (active or former) vs. non-smoker status was associated with more advanced clinicopathological characteristics and poor oncological outcomes in both BC and BCL groups.Conclusions: This population-based registry study in patients with BC revealed the presence of smoking history (active or former) in almost two-thirds of patients in both BC and BLC groups, which was associated with more advanced clinicopathological characteristics and poor oncological outcomes in both BC and BCL groups.en_US
dc.description.sponsorshipAstra Zeneca-Turkiyeen_US
dc.description.sponsorshipAstra Zeneca-Turkiye provided unconditional support for updating the Turkish Association of Urooncology Bladder Cancer Database.en_US
dc.identifier.doi10.4274/uob.galenos.2023.2023.2.2
dc.identifier.endpage149en_US
dc.identifier.issn2147-2270
dc.identifier.issue4en_US
dc.identifier.startpage144en_US
dc.identifier.urihttps://doi.org/10.4274/uob.galenos.2023.2023.2.2
dc.identifier.urihttps://hdl.handle.net/11454/105216
dc.identifier.volume22en_US
dc.identifier.wosWOS:001117734200002en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherGalenos Publ Houseen_US
dc.relation.ispartofUroonkoloji Bulteni-Bulletin of Urooncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240831_Uen_US
dc.subjectSmoking Statusen_US
dc.subjectBladder Canceren_US
dc.subjectLung Canceren_US
dc.subjectSecond Primary Canceren_US
dc.subjectClinicopathological Featuresen_US
dc.subjectOncological Outcomeen_US
dc.titleSmoking Status in Relation to Clinicopathological Characteristics, Oncological Outcome, and Presence of Second Primary Lung Cancer in Patients with Bladder Cancer: A Population-based Registry Studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu